Suppression of hepatic stellate cell activation by microRNA-29b.
about
Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosisMicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signalingHepatic Stellate Cells and microRNAs in Pathogenesis of Liver FibrosisCytoglobin as a Marker of Hepatic Stellate Cell-derived MyofibroblastsThe role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosisHepatitis B Virus Infection, MicroRNAs and Liver DiseaseTherapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?Reversibility and heritability of liver fibrosis: Implications for research and therapyBovine Leukemia Virus Small Noncoding RNAs Are Functional Elements That Regulate Replication and Contribute to Oncogenesis In VivoDown-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma.Evolving therapies for liver fibrosis.Discoidin domain receptor functions in physiological and pathological conditions.MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidaseMicroRNA-29b Contributes to Collagens Imbalance in Human Osteoarthritic and Dedifferentiated Articular Chondrocytes.MicroRNA function in the profibrogenic interplay upon chronic liver disease.MicroRNA mimicry blocks pulmonary fibrosis.MicroRNA 29 targets nuclear factor-κB-repressing factor and Claudin 1 to increase intestinal permeability.Anti-fibrotic Role of miR-214 in Thioacetamide-induced Liver Cirrhosis in Rats.Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature.MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresiaThe miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury.Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis.Discoidin domain receptor tyrosine kinases: new players in cancer progressionSalvianolic acid B-induced microRNA-152 inhibits liver fibrosis by attenuating DNMT1-mediated Patched1 methylation.miRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation.Novel form of miR-29b suppresses bleomycin-induced pulmonary fibrosisCoding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis.MicroRNA-29B (mir-29b) regulates the Warburg effect in ovarian cancer by targeting AKT2 and AKT3Role of microRNAs in gastrointestinal smooth muscle fibrosis and dysfunction: novel molecular perspectives on the pathophysiology and therapeutic targeting.MAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU TabletHydatid cyst fluid promotes peri-cystic fibrosis in cystic echinococcosis by suppressing miR-19 expression.MicroRNA and nephropathy: emerging concepts.MicroRNA-29b regulation of abdominal aortic aneurysm development.Apoptosis and necrosis in the liverLong non-coding RNA PVT1 activates hepatic stellate cells through competitively binding microRNA-152.MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.miRNAs regulate expression and function of extracellular matrix molecules.Translating an understanding of the pathogenesis of hepatic fibrosis to novel therapiesMicroRNAs: the fine modulators of liver development and function.Illustrating the interplay between the extracellular matrix and microRNAs.
P2860
Q21560965-B0D17D87-7890-49D6-BE12-4FE7C69AC5F9Q26740198-3F3AAD31-5340-4B4E-8E2A-EA95EB118423Q26752932-34FB6C40-3E15-428D-8F0C-688C32AB957FQ26776162-F5133AA9-0B50-4EF8-82C4-6BE59B677FE6Q26797382-929ED8BB-EEBE-4597-A507-CC6E8898F7FEQ26801511-38EA45E3-DF06-4574-9ADF-2493AAAC3D12Q26829662-0AFB01E6-51F4-4E74-9942-F8F1578DFB51Q27026622-5B6658E5-BAF3-4A62-A9E5-C714A0165CC2Q27314611-957A6356-C12E-4D6E-82A2-DE02E8082286Q30407678-3A17675B-14FD-45C5-8B3E-A7D90F3498D3Q30539166-7893A0F8-7F71-4739-A0FC-EB3199BFB6CFQ33611605-BE685F8A-9CDA-480D-88DB-A578C44888C1Q33662692-3D40318C-4B82-4BE8-BBC1-40EC99E3171FQ33762372-1459ECA1-0C70-4361-9BF2-E276E1F2A716Q33907481-0710C6BB-AEDB-415E-9A08-810666CFB0ABQ34880449-DBC20C97-4599-4285-93F4-2068356412AAQ35002321-C74AB286-5A12-42A3-A770-08AAF438050DQ35574298-B35E557B-B33A-4EBE-943C-DFCF7A632EA6Q35644474-269741C7-47C0-4D14-AAD3-C2EC3E4257B6Q35690705-E2ABEEC1-A997-41C1-BC76-1A27942F5EE7Q35786347-8A369728-736A-4AAE-83CA-7053408A42E2Q35877447-EDD9C36A-98C3-4853-9180-D83C35235AA4Q35957518-3E4AD4F1-12BD-4D2E-A88E-6482384C3472Q36232847-92CFD2F0-5A6B-41A3-83C3-1EDF3DF93EDEQ36251701-CD07676F-4C2B-4AAD-80AC-5BE10559DE8EQ36289509-A6F8FBA8-FDE7-415A-847D-34904705AD6CQ36326679-EE8A27E5-7C33-462C-8B6C-2BA0CB69866DQ36562171-1F2A5712-9E07-414B-B15C-2BE38A6059B3Q36775830-A4DCFDA7-01AA-45DD-A831-20F9CD21910FQ36896262-9683F7A6-E157-4D9F-BE4D-006684910FEFQ36898564-C35BDAEF-EF2F-461A-ABFD-3301B2635D46Q37221074-D80634E1-A81E-4FA5-9FC4-838E9530DC2CQ37275059-C9B45A3A-D8D8-48E8-8BA9-86A7E931FA61Q37403072-72547BFB-F7FF-4EF8-83BB-5CECA2095325Q37665189-B66345D9-F5B2-4168-98BA-33BB125EE189Q38050081-23CAA574-EA30-4981-B93C-FB05C9F2E378Q38060445-F767F175-343F-45EE-AD48-AE37D860E0DBQ38073028-A0D11526-1C13-49CA-B081-066E81C26DE5Q38187190-94A941DF-C52D-4065-95E4-214C59E99DFCQ38206794-A61A5A65-767D-42DF-98A3-04B7A7685756
P2860
Suppression of hepatic stellate cell activation by microRNA-29b.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Suppression of hepatic stellate cell activation by microRNA-29b.
@en
Suppression of hepatic stellate cell activation by microRNA-29b.
@nl
type
label
Suppression of hepatic stellate cell activation by microRNA-29b.
@en
Suppression of hepatic stellate cell activation by microRNA-29b.
@nl
prefLabel
Suppression of hepatic stellate cell activation by microRNA-29b.
@en
Suppression of hepatic stellate cell activation by microRNA-29b.
@nl
P2093
P1476
Suppression of hepatic stellate cell activation by microRNA-29b.
@en
P2093
Katsutoshi Yoshizato
Kazuo Ikeda
Norifumi Kawada
Tomohiro Ogawa
Yumiko Sekiya
P356
10.1016/J.BBRC.2011.07.041
P407
P577
2011-07-21T00:00:00Z